title: The effects of a high-fat, high-cholesterol diet on markers of uterine contractility during parturition in the rat.
abstract: Increasing levels of obesity within women of reproductive age is a major concern in the UK. Approximately, 13% of women aged <30 and 22% of 31- to 40-year-old women are obese. Obesity increases complications during pregnancy and the risk of caesarean section due to prolonged labour and poor uterine activity. The aim was to investigate whether a high-fat, high-cholesterol (HFHC) diet decreases markers of uterine contractility during parturition in the rat. Female Wistar rats were fed control (CON, n=10) or HFHC (n=10) diets for 6 weeks. Animals were mated and, once pregnant, maintained on their diet throughout gestation. On gestational day 19, rats were monitored continuously and killed at the onset of parturition. Body and fat depot weights were recorded. Myometrial tissue was analysed for cholesterol (CHOL), triglycerides (TAG), and expression of the contractile associated proteins gap junction protein alpha 1 (GJA1; also known as connexin-43, CX-43), prostaglandin-endoperoxide synthase 2 (PTGS2; also known as cyclo-oxygenase-2, COX-2) and caveolin-1 (CAV1) and maternal plasma for prostaglandin F(2)(α) (PGF(2)(α)) and progesterone. HFHC fed rats gained greater weight than CON (P<0.003) with significant increases in peri-renal fat (P<0.01). The HFHC diet increased plasma CHOL, TAG and progesterone, but decreased PGF(2)(α) versus CON (P<0.01, P<0.01, P=0.05 and P<0.02 respectively). Total CHOL and TAG levels of uterine tissue were similar. However, HFHC fed rats showed significant increases in PTGS2 (P<0.037), but decreases in GJA1 and CAV1 (P=0.059). In conclusion, a HFHC diet significantly increases body weight and alters lipid profiles that correlate with decreases in key markers of uterine contractility. Further work is required to ascertain whether these changes have adverse effects on uterine activity.
authors.affiliation: Division of Nutritional Sciences, School of Biosciences, University of Nottingham, Sutton Bonington Campus, Loughborough, Leicestershire LE12 5RD, UK. matthew.elmes@nottingham.ac.uk
authors.forename: M J
authors.initials: MJ
authors.lastname: Elmes
authors.forename: D S-Y
authors.initials: DS
authors.lastname: Tan
authors.forename: Z
authors.initials: Z
authors.lastname: Cheng
authors.forename: D C
authors.initials: DC
authors.lastname: Wathes
authors.forename: S
authors.initials: S
authors.lastname: McMullen
mesh_terms: D000818:Animals; D015153:Blotting, Western; D001835:Body Weight / Q000187:drug effects; D051242:Caveolin 1 / Q000378:metabolism*; D002784:Cholesterol / Q000097:blood; D018031:Connexin 43 / Q000378:metabolism*; D051546:Cyclooxygenase 2 / Q000378:metabolism*; D004041:Dietary Fats / Q000008:administration & dosage*; D015237:Dinoprost / Q000097:blood; D005260:Female; D036801:Parturition / Q000187:drug effects*; D011247:Pregnancy; D011374:Progesterone / Q000097:blood; D011863:Radioimmunoassay; D051381:Rats; D017208:Rats, Wistar; D014280:Triglycerides / Q000097:blood; D014590:Uterine Contraction / Q000187:drug effects*
chemical_list: C495537:Cav1 protein, rat; D051242:Caveolin 1; D018031:Connexin 43; D004041:Dietary Fats; D014280:Triglycerides; D011374:Progesterone; D002784:Cholesterol; D015237:Dinoprost; D051546:Cyclooxygenase 2; C489691:Ptgs2 protein, rat